Agios Pharmaceuticals competitors

Agios Pharmaceuticals's competitors include Merrimack Pharmaceuticals, TESARO, AVEO Pharmaceuticals and Infinity Pharmaceuticals
Add company...
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Infinity Pharmaceuticals
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Founding Date
Founding Date
2008
Founding Date
2000
Founding Date
2010
Founding Date
2001
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
Waltham, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Employees
Employees
38233% increase
Employees
294
Employees
446
Employees
20
Employees
23
Valuation ($)
Valuation ($)
5.4 b
Valuation ($)
120.4 m
Valuation ($)
2.3 b
Valuation ($)
261.5 m
Valuation ($)
96.4 m
Facebook likes
Facebook likes
N/A
Facebook likes
647
Facebook likes
N/A
Facebook likes
445
Facebook likes
N/A
Twitter followers
Twitter followers
513
Twitter followers
1.1 k
Twitter followers
1.8 k
Twitter followers
650
Twitter followers
1.8 k

Financial

Revenue (est.)
Revenue (est.)
$43m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$223.3m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($314.7m) (FY, 2017)
Net income
$470.9m (FY, 2017)
Net income
($496.1m) (FY, 2017)
Net income
($26.9m) (FY, 2016)
Net income
($41.8m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 79.4m
Total funding raised
$ 161m
Total funding raised
$ 138.2m
Total funding raised
$ 178.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
294

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
TESARO
HQ
Waltham, US
Employees
446

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
20

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
23

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

View company